News & Articles

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection

Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA

Researchers from the University of Oxford, UK, are developing rapid testing technology for COVID-19

The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes

IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19

Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020

Join this webinar to explore the biological and technical considerations when developing, testing, optimizing, and validating multiplex panels

The new products are said to offer increased flexibility and efficiency for low- to high-volume molecular testing laboratories

The new tubes and racks promise long-term stability and uninterrupted operation in biobanking and compound storage applications

These CAR-T cell therapies are designed to be used in the treatment of hematological malignancies

Panel includes atypical pathogens and is expected to substantially increase total addressable market for the Unyvero system in the U.S.

Joint venture to develop next generation cell and gene therapies incorporating Affimer proteins

Meet the inflammation and immunity researcher studying the fundamental cellular mechanisms behind uncontrolled inflammatory responses to allergens

Researchers at Queen’s University, Canada, explain how their new core facility and its cutting-edge flow cytometry and cell sorting technology are accelerating cardiopulmonary research

A population genetics scientist tells SelectScience how she’s combating red mite infestations on chicken farms